targeted radionuclide therapy

Open Access
Modeling Early Radiation DNA Damage Occurring During ¹⁷⁷Lu-DOTATATE Radionuclide Therapy
Giulia Tamborino, Yann Perrot, Marijke De Saint-Hubert, Lara Struelens, Julie Nonnekens, Marion De Jong, Mark W. Konijnenberg and Carmen Villagrasa

Journal of Nuclear Medicine May 1, 2022, 63 (5) 761-769; DOI: https://doi.org/10.2967/jnumed.121.262610
You have access
Intraarterial Peptide Receptor Radionuclide Therapy Using ⁹⁰Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors
Courtney Lawhn-Heath, Nicholas Fidelman, Bryant Chee, Salma Jivan, Evan Armstrong, Li Zhang, Sheila Lindsay, Emily K. Bergsland and Thomas A. Hope

Journal of Nuclear Medicine February 1, 2021, 62 (2) 221-227; DOI: https://doi.org/10.2967/jnumed.119.241273
Open Access
Preclinical Characterization of the Radioimmunoconjugate ¹¹¹In or ⁹⁰Y-FF-21101 Against a P-Cadherin–Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate
Yuichi Funase, Eri Nakamura, Masamichi Kajita, Yasutaka Saito, Shinobu Oshikiri, Michi Kitano, Masahiko Tokura, Akihiro Hino and Tomoya Uehara

Journal of Nuclear Medicine February 1, 2021, 62 (2) 232-239; DOI: https://doi.org/10.2967/jnumed.120.245837
Open Access
Combination Strategies to Improve Targeted Radionuclide Therapy
Tiffany G. Chan, Edward O’Neill, Christine Habjan and Bart Cornelissen

Journal of Nuclear Medicine November 1, 2020, 61 (11) 1544-1552; DOI: https://doi.org/10.2967/jnumed.120.248062
Open Access
¹⁷⁷Lu-NM600 Targeted Radionuclide Therapy Extends Survival in Syngeneic Murine Models of Triple-Negative Breast Cancer
Reinier Hernandez, Joseph J. Grudzinski, Eduardo Aluicio-Sarduy, Christopher F. Massey, Anatoly N. Pinchuk, Ariana N. Bitton, Ravi Patel, Ray Zhang, Aakarsha V. Rao, Gopal Iyer, Jonathan W. Engle and Jamey P. Weichert

Journal of Nuclear Medicine August 1, 2020, 61 (8) 1187-1194; DOI: https://doi.org/10.2967/jnumed.119.236265
You have access
Preclinical Characterization of ^86/90Y-NM600 in a Variety of Murine and Human Cancer Tumor Models
Joseph J. Grudzinski, Reinier Hernandez, Ian Marsh, Ravi B. Patel, Eduardo Aluicio-Sarduy, Jon Engle, Zachary Morris, Bryan Bednarz and Jamey Weichert

Journal of Nuclear Medicine November 1, 2019, 60 (11) 1622-1628; DOI: https://doi.org/10.2967/jnumed.118.224808
You have access
New Developments in Peptide Receptor Radionuclide Therapy
Guillaume P. Nicolas, Alfred Morgenstern, Margret Schottelius and Melpomeni Fani

Journal of Nuclear Medicine February 1, 2019, 60 (2) 167-171; DOI: https://doi.org/10.2967/jnumed.118.213496
You have access
Advancing Targeted Radionuclide Therapy Through the National Cancer Institute’s Small Business Innovation Research Pathway
Kaveh Zakeri, Deepa Narayanan, Greg Evans, Pataje Prasanna, Jeffrey C. Buchsbaum, Bhadrasain Vikram and Jacek Capala

Journal of Nuclear Medicine January 1, 2019, 60 (1) 41-49; DOI: https://doi.org/10.2967/jnumed.118.214684
You have access
Combined VLA-4–Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma
Jaeyeon Choi, Wissam Beaino, Ronald J. Fecek, Kellsye P.L. Fabian, Charles M. Laymon, Brenda F. Kurland, Walter J. Storkus and Carolyn J. Anderson

Journal of Nuclear Medicine December 1, 2018, 59 (12) 1843-1849; DOI: https://doi.org/10.2967/jnumed.118.209510
You have access
Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter–Expressing Tumors
Aiko Yamaguchi, Hirofumi Hanaoka, Tetsuya Higuchi and Yoshito Tsushima

Journal of Nuclear Medicine May 1, 2018, 59 (5) 815-821; DOI: https://doi.org/10.2967/jnumed.117.201525

Main menu

User menu

Search

targeted radionuclide therapy